Susquehanna International Group, LLP Monte Rosa Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$3.59 - $6.97 $5,026 - $9,758	-1,400 Reduced 1.93%	71,100 $376,000
Q2 2024 Aug 15, 2024	BUY	$3.38 - $7.86 $25,350 - $58,950	7,500 Added 11.54%	72,500 $271,000
Q1 2024 May 07, 2024	SELL	$4.26 - $8.46 $196,386 - $390,006	-46,100 Reduced 41.49%	65,000 $458,000
Q4 2023 Feb 14, 2024	BUY	$2.5 - $5.93 $200,000 - $474,400	80,000 Added 257.23%	111,100 $627,000
Q3 2023 Nov 14, 2023	BUY	$4.78 - $7.22 $44,932 - $67,868	9,400 Added 43.32%	31,100 $148,000
Q2 2023 Aug 11, 2023	SELL	$4.53 - $8.4 $4,983 - $9,240	-1,100 Reduced 4.82%	21,700 $148,000
Q1 2023 May 16, 2023	SELL	$5.95 - $8.21 $73,185 - $100,983	-12,300 Reduced 35.04%	22,800 $177,000
Q4 2022 Feb 14, 2023	BUY	$6.71 - $9.72 $235,521 - $341,172	35,100 New	35,100 $267,000

43.9M

141K

31.2K

Ticker GLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,713,900
Market Cap $329M
Description
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.